Scilex Holding Co

Scilex Holding Company (Nasdaq: SCLX) is a specialty pharmaceutical company focused on non-opioid pain management products. The company reached the public markets through a business combination with Vickers Vantage Corp. I, a blank-check company that completed its IPO in 2021, with Sorrento Therapeutics serving as a significant pre-combination stakeholder. At the time of its November 2022 Form 10-Q filing, Scilex was finalizing its transition to a standalone publicly traded entity in the healthcare sector. The filing covers operational and financial disclosures ahead of the merger's December 2022 close. For full filing history, ownership data, and deal metrics on SCLX, sign up for complete access at SpacDesk.